We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-9.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.67B
AUM Growth
-$658M
Cap. Flow
+$79.2M
Cap. Flow %
1.19%
Top 10 Hldgs %
57.1%
Holding
295
New
64
Increased
76
Reduced
63
Closed
70

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$87.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$59.2M
3
STAA icon
STAAR Surgical
STAA
+$42.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$35.7M
5
SNN icon
Smith & Nephew
SNN
+$34.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81.1M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$79.9M
3
GSK icon
GSK
GSK
+$73.2M
4
HUM icon
Humana
HUM
+$69.2M
5
BUD icon
AB InBev
BUD
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 35.45%
2 Consumer Discretionary 6.85%
3 Consumer Staples 5.47%
4 Technology 5.39%
5 Communication Services 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
26
Medtronic
MDT
$110B
$48.6M 0.73%
541,237
-208,927
-28% -$18.7M
OFIX icon
27
Orthofix Medical
OFIX
$493M
$48.3M 0.72%
2,964,000
-36,000
-1% -$632K
SMPL icon
28
Simply Good Foods
SMPL
$1B
$46.6M 0.7%
1,351,593
+166,319
+14% +$6.02M
GOOGL icon
29
Alphabet (Google) Class A
GOOGL
$4.62T
$45.9M 0.69%
297,000
+85,112
+40% +$15.4M
MDGL icon
30
Madrigal Pharmaceuticals
MDGL
$11.7B
$45M 0.67%
135,883
+35,883
+36% +$11.8M
XRAY icon
31
Dentsply Sirona
XRAY
$2.86B
$44.8M 0.67%
3,000,148
-499,480
-14% -$8.85M
KURA icon
32
Kura Oncology
KURA
$841M
$43.4M 0.65%
6,572,000
+772,000
+13% +$6.02M
ADBE icon
33
Adobe
ADBE
$102B
$42.6M 0.64%
111,200
+43,188
+64% +$18.5M
DPZ icon
34
Domino's
DPZ
$12.2B
$41.4M 0.62%
90,068
+40,206
+81% +$18.2M
CYTK icon
35
Cytokinetics
CYTK
$10.7B
$41.1M 0.62%
1,023,390
-288,610
-22% -$13.3M
SXT icon
36
Sensient Technologies
SXT
$5.41B
$40.9M 0.61%
549,827
+199,827
+57% +$14.5M
BHVN icon
37
Biohaven
BHVN
$2.07B
$40.2M 0.6%
1,673,422
+1,124
+0.1% +$39.6K
AUPH icon
38
Aurinia Pharmaceuticals
AUPH
$1.92B
$40.2M 0.6%
5,000,000
-1,400,000
-22% -$11.3M
KDP icon
39
Keurig Dr Pepper
KDP
$42.3B
$37.6M 0.56%
+1,099,716
New +$35.7M
S icon
40
SentinelOne
S
$7.19B
$33.9M 0.51%
1,865,801
+14,623
+0.8% +$317K
ENR icon
41
Energizer
ENR
$1.48B
$33.8M 0.51%
1,128,144
+138,718
+14% +$4.44M
PLNT icon
42
Planet Fitness
PLNT
$4.43B
$33.6M 0.5%
347,558
+122,612
+55% +$12.3M
CENTA icon
43
Central Garden & Pet Co Class A
CENTA
$2.42B
$33.6M 0.5%
1,025,085
+229,324
+29% +$7.29M
MRK icon
44
Merck
MRK
$316B
$29.1M 0.44%
+324,039
New +$30.3M
SNY icon
45
Sanofi
SNY
$102B
$29.1M 0.44%
524,000
-724,000
-58% -$39.2M
IMCR icon
46
Immunocore
IMCR
$1.69B
$29M 0.43%
978,000
-222,000
-19% -$6.66M
DYN icon
47
Dyne Therapeutics
DYN
$4.85B
$29M 0.43%
2,768,000
+1,803,482
+187% +$25.8M
AVNS
48
DELISTED
Avanos Medical
AVNS
$28.7M 0.43%
+2,000,000
New +$31.2M
TOST icon
49
Toast
TOST
$19.6B
$28.6M 0.43%
863,723
+96,191
+13% +$3.6M
TXRH icon
50
Texas Roadhouse
TXRH
$13.7B
$27.4M 0.41%
164,701
+54,701
+50% +$9.68M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Armistice Capital held 295 positions worth $6.67B, down 9% from $7.33B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Armistice Capital's Q1 2025 filing shows 64 new, 76 increased, 63 reduced and 70 closed positions. Its largest new stake was Freshpet: 716,960 shares worth $59.6M. The largest sale was Vertex Pharmaceuticals, an estimated $81.1M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q1 2025 buy was Freshpet: 716,960 shares worth $59.6M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q1 2025, an estimated $59.2M increase.
  • Armistice Capital's biggest Q1 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $81.1M.
  • Armistice Capital fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $79.9M.
  • Armistice Capital's ten largest holdings make up 57% of its $6.67B portfolio in Q1 2025.
  • Armistice Capital opened 64 new positions and closed 70 in Q1 2025.
  • Armistice Capital's portfolio value fell 9% quarter-over-quarter to $6.67B.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.